Skip to main content
SpringerLink
Log in

Complicated Community-Acquired Soft Tissue Infection by MRSA from Porcine Origin

  • Case Report
  • Published:
Infection Aims and scope Submit manuscript

An Erratum to this article was published on 28 December 2007

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is a rare cause of community acquired soft tissue infection in Europe. We report a case of severe soft tissue infection caused by a MRSA strain originating from a pig bite.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hsueh PR, Chen WH, Luh KT: Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991–2003 at a university hospital in Taiwan. Int J Antimicrob Agents 2005; 26: 463–472.

    Article  PubMed  CAS  Google Scholar 

  2. Paterson DL: “Collateral damage” from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis 2004; 38: S341–S345.

    Article  PubMed  CAS  Google Scholar 

  3. Albrich WC, Monnet DL, Harbarth S: Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis 2004; 10: 514–517.

    PubMed  Google Scholar 

  4. Goossens H, Ferech M, Vander Stichele R, Elseviers M: Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579–587.

    PubMed  Google Scholar 

  5. Malhotra-Kumar S, Lammens C, Coenen S, Van Herck K, Goossens H: Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebocontrolled study. Lancet 2007; 369: 482–490.

    Article  PubMed  CAS  Google Scholar 

  6. de With K, Bergner J, Buhner R, Dorje F, Gonnermann C, Haber M, Hartmann M, Rothe U, Strehl E, Steib-Bauert M, Kern WV: Antibiotic use in German university hospitals 1998–2000 (Project INTERUNI-II). Int J Antimicrob Agents 2004; 24: 213–218.

    Article  PubMed  Google Scholar 

  7. Janknegt R, Oude Lashof A, Gould IM, van der Meer JW: Antibiotic use in Dutch hospitals 1991–1996. J Antimicrob Chemother 2000; 45: 251–256.

    Article  PubMed  CAS  Google Scholar 

  8. Lodise TP, McKinnon PS: Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia. Diagn Microbiol Infect Dis 2005; 52: 113–122.

    Article  PubMed  Google Scholar 

  9. Lee NY, Lee HC, Ko NY, Chang CM, Shih HI, Wu CJ, Ko WC: Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Infect Control Hosp Epidemiol 2007; 28: 713–719.

    Article  PubMed  Google Scholar 

  10. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2007. Oslo, 2006. Available at: http://www.whocc.no/atcddd Accessed 9 September 2007.

  11. Platt R: Toward better benchmarking. Infect Control Hosp Epidemiol 2005; 26: 433–434.

    Article  PubMed  Google Scholar 

  12. Westh H: Benchmarking. In: Gould IM, Meer JWM van der (eds): Antibiotic policies. Theory and practice. Kluwer Academic, New York 2005, pp 119–132.

    Chapter  Google Scholar 

  13. Polk RE, Fox C, Mahoney A, Letcavage J, MacDougall C: Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis 2007; 44: 664–670.

    Article  PubMed  CAS  Google Scholar 

  14. Kern WV, Steib-Bauert M, de With K, Reuter S, Bertz H, Frank U, von Baum H: Fluoroquinolone consumption and resistance in haematology-oncology patients: ecological analysis in two university hospitals 1999–2002. J Antimicrob Chemother 2005; 55: 57–60.

    Article  PubMed  CAS  Google Scholar 

  15. Kern WV, de With K, Steib-Bauert M, Fellhauer M, Plangger A, Probst W: Antibiotic use in non-university regional acute care general hospitals in southwestern Germany, 2001–2002. Infection 2005; 33: 333–339.

    Article  PubMed  CAS  Google Scholar 

  16. de With K, Maier L, Steib-Bauert M, Kern P, Kern WV: Trends in antibiotic use at a university hospital: defined or prescribed daily doses? Patient days or admissions as denominator? Infection 2006; 34: 91–94.

    Article  PubMed  Google Scholar 

  17. Kritsotakis EI, Gikas A: Surveillance of antibiotic use in hospitals: methods, trends and targets. Clin Microbiol Infect 2006; 12: 701–704.

    PubMed  CAS  Google Scholar 

  18. Keenan SP, Dodek P, Martin C, Priestap F, Norena M, Wong H: Variation in length of intensive care unit stay after cardiac arrest: where you are is as important as who you are. Crit Care Med 2007; 35: 836–841.

    Article  PubMed  Google Scholar 

  19. DeFrances CJ, Hall MJ: National hospital discharge survey. Adv Data 2005; 2007: 1–19.

    Google Scholar 

  20. Westert GP, Lagoe RJ, Keskimaki I, Leyland A, Murphy M: An international study of hospital readmissions and related utilization in Europe and the USA. Health Policy 2002; 61: 269–278.

    Article  PubMed  Google Scholar 

  21. Theurl E, Winner H: The impact of hospital financing on the length of stay: evidence from Austria. Health Policy 2007; 82: 375–389.

    Article  PubMed  Google Scholar 

  22. Esposito S, Noviello S, Leone S, Tice A, Seibold G, Nathwani D, Scaglione F: Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison. Int J Antimicrob Agents 2004; 24: 473–478.

    Article  PubMed  CAS  Google Scholar 

  23. Monnet DL: ABC Calc — Antibiotic consumption calculator [Microsoft Excel application]. Version 3.0. Statens Serum Institute, Copenhagen, 2005.

    Google Scholar 

  24. Loeffler JM, Garbino J, Lew D, Harbarth S, Rohner P: Antibiotic consumption, bacterial resistance and their correlation in a Swiss university hospital and its adult intensive care units. Scand J Infect Dis 2003; 35: 843–850.

    Article  PubMed  Google Scholar 

  25. Ruttimann S, Keck B, Hartmeier C, Maetzel A, Bucher HC: Longterm antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital. Clin Infect Dis 2004; 38: 348–356.

    Article  PubMed  Google Scholar 

  26. Mach R, Vlcek J, Prusova M, Batka P, Rysavy V, Kubena A: Impact of a multidisciplinary approach on antibiotic consumption, cost and microbial resistance in a Czech hospital. Pharm World Sci 2007; 29: 565–572.

    Article  PubMed  Google Scholar 

  27. Muller-Pebody B, Muscat M, Pelle B, Klein BM, Brandt CT, Monnet DL: Increase and change in pattern of hospital antimicrobial use, Denmark, 1997–2001. J Antimicrob Chemother 2004; 54: 1122–1126.

    Article  PubMed  Google Scholar 

  28. DANMAP: Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark. 2006. ISSN 1600–2032.

  29. Naaber P, Koljalg S, Maimets M: Antibiotic usage and resistance - trends in Estonian University Hospitals. Int J Antimicrob Agents 2000; 16: 309–315.

    Article  PubMed  CAS  Google Scholar 

  30. Muller A, Monnet DL, Talon D, Henon T, Bertrand X: Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospital. Br J Clin Pharmacol 2006; 61: 585–591.

    Article  PubMed  CAS  Google Scholar 

  31. Rogues AM, Placet-Thomazeau B, Parneix P, Vincent I, Ploy MC, Marty N, Merillou B, Labadie JC, Gachie JP: Use of antibiotics in hospitals in south-western France. J Hosp Infect 2004; 58: 187–192.

    Article  PubMed  CAS  Google Scholar 

  32. de With K, Steib-Bauert M, Straach P, Kern WV: Is there significant regional variation in hospital antibiotic consumption in Germany? Infection 2006; 34: 274–277.

    Article  PubMed  Google Scholar 

  33. de With K, Meyer E, Steib-Bauert M, Schwab F, Daschner FD, Kern WV: Antibiotic use in two cohorts of German intensive care units. J Hosp Infect 2006; 64: 231–237.

    Article  PubMed  Google Scholar 

  34. Bassetti M, Di Biagio A, Rebesco B, Amalfitano ME, Topal J, Bassetti D: The effect of formulary restriction in the use of antibiotics in an Italian hospital. Eur J Clin Pharmacol 2001; 57: 529–534.

    Article  PubMed  CAS  Google Scholar 

  35. Blix HS, Hartug S: Hospital usage of antibacterial agents in relation to size and type of hospital and geographical situation. Pharmacoepidemiol Drug Saf 2005; 14: 647–649.

    Article  PubMed  Google Scholar 

  36. Goryachkina K, Babak S, Burbello A, Wettemark B, Bergman U: Quality use of medicines: a new method of combining antibiotic consumption and sensitivity data-application in a Russian hospital. Pharmacoepidemiol Drug Saf 2008; 17: 636–644.

    Article  PubMed  Google Scholar 

  37. Hermosilla Najera L, Canut Blasco A, Ulibarrena Sanz M, Abasolo Osinaga E, Abecia Inchaurregui LC: Trends in antimicrobial utilization at a Spanish general hospital during a 5-year period. Pharmacoepidemiol Drug Saf 2003; 12: 243–247.

    Article  PubMed  Google Scholar 

  38. Walther SM, Erlandsson M, Burman LG, Cars O, Gill H, Hoffman M, Isaksson B, Kahlmeter G, Lindgren S, Nilsson L, Olsson-Liljequist B, Hanberger H: Antibiotic prescription practices, consumption and bacterial resistance in a cross section of Swedish intensive care units. Acta Anaesthesiol Scand 2002; 46: 1075–1081.

    Article  PubMed  CAS  Google Scholar 

  39. Bergman U, Risinggard H, Vlahovic-Palcevski V, Ericsson O: Use of antibiotics at hospitals in Stockholm: a benchmarking project using internet. Pharmacoepidemiol Drug Saf 2004; 13: 465–471.

    Article  PubMed  Google Scholar 

  40. SWEDRES: A report on Swedish antibiotic utilisation and resistance in human medicine 2006. ISSN 1400–3473.

  41. Liem TB, Filius FM, van der Linden PD, Janknegt R, Natsch S, Vulto AG: Changes in antibiotic use in Dutch hospitals over a six-year period: 1997 to 2002. Neth J Med 2005; 63: 354–360.

    PubMed  CAS  Google Scholar 

  42. Filius PM, Liem TB, van der Linden PD, Janknegt R, Natsch S, Vulto AG, Verbrugh HA: An additional measure for quantifying antibiotic use in hospitals. J Antimicrob Chemother 2005; 55: 805–808.

    Article  PubMed  CAS  Google Scholar 

  43. SWAB: NethMap 2007 — consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in The Netherlands.

  44. Curtis C, Marriott J, Langley C: Development of a prescribing indicator for objective quantification of antibiotic usage in secondary care. J Antimicrob Chemother 2004; 54: 529–533.

    Article  PubMed  CAS  Google Scholar 

  45. Dancer SJ, Coyne M, Robertson C, Thomson A, Guleri A, Alcock S: Antibiotic use is associated with resistance of environmental organisms in a teaching hospital. J Hosp Infect 2006; 62: 200–206.

    Article  PubMed  CAS  Google Scholar 

  46. Vander Stichele RH, Elseviers MM, Ferech M, Blot S, Goossens H: Hospital consumption of antibiotics in 15 European countries: results of the ESAC retrospective data collection (1997–2002). J Antimicrob Chemother 2006; 58: 159–167.

    Article  PubMed  CAS  Google Scholar 

  47. MacKenzie FM, Monnet DL, Gould IM: Relationship between the number of different antibiotics used and the total use of antibiotics in European hospitals. J Antimicrob Chemother 2006; 58: 657–660.

    Article  PubMed  CAS  Google Scholar 

  48. Ansari F: Utilization review of systemic antiinfective agents in a teaching hospital in Tehran, Iran. Eur J Clin Pharmacol 2001; 57: 541–546.

    Article  PubMed  CAS  Google Scholar 

  49. Apisarnthanarak A, Danchaivijitr S, Khawcharoenporn T, Limsrivilai J, Warachan B, Bailey TC, Fraser VJ: Effectiveness of education and an antibiotic-control program in a tertiary care hospital in Thailand. Clin Infect Dis 2006; 42: 768–775.

    Article  PubMed  Google Scholar 

  50. Bantar C, Sartori B, Vesco E, Heft C, Saul M, Salamone F, Oliva ME: A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. Clin Infect Dis 2003; 37: 180–186.

    Article  PubMed  Google Scholar 

  51. Berild D, Ringertz SH, Lelek M, Fosse B: Antibiotic guidelines lead to reductions in the use and cost of antibiotics in a university hospital. Scand J Infect Dis 2001; 33: 63–67.

    Article  PubMed  CAS  Google Scholar 

  52. Kritsotakis EI, Assithianakis P, Kanellos P, Tzagarakis N, Ioannides MC, Gikas A: Surveillance of monthly antimicrobial consumption rates stratified by patient-care area: a tool for triggering and targeting antibiotic policy changes in the hospital. J Chemother 2006; 18: 394–401.

    PubMed  CAS  Google Scholar 

  53. White RL, Friedrich LV, Mihm LB, Bosso JA: Assessment of the relationship between antimicrobial usage and susceptibility: differences between the hospital and specific patient-care areas. Clin Infect Dis 2000; 31: 16–23.

    Article  PubMed  CAS  Google Scholar 

  54. Ronning M, Blix HS, Strom H, Skovlund E, Andersen M, Stichele RV: Problems in collecting comparable national drug use data in Europe: the example of antibacterials. Eur J Clin Pharmacol 2003; 58: 843–849.

    PubMed  Google Scholar 

  55. Monnet DL: Measuring antimicrobial use: the way forward. Clin Infect Dis 2007; 44: 671–673.

    Article  PubMed  Google Scholar 

  56. Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM: Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007; 44: 159–177.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Microbiology, St. Jozefskliniek, Roeselaarsestraat 47, B-8870, Izegem, Belgium

    Ph. Declercq

  2. Dept. of Orthopedic Surgery, St. Jozefskliniek, Izegem, Belgium

    D. Petré

  3. Dept. of Microbiology, AZ St. Jan, Brugge, Belgium

    B. Gordts

  4. Dept. of Medical Microbiology and Infectious Diseases, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands

    A. Voss

Authors
  1. Ph. Declercq
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Petré
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Gordts
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Voss
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ph. Declercq.

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/s15010-007-9029-9.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Declercq, P., Petré, D., Gordts, B. et al. Complicated Community-Acquired Soft Tissue Infection by MRSA from Porcine Origin. Infection 36, 590–592 (2008). https://doi.org/10.1007/s15010-007-7029-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-007-7029-4

Keywords

Search

Navigation